Patent Application
Utility
App. No. 18/667,272
· Confirmation No. 1187
USE OF FERRIC CITRATE IN THE TREATMENT OF AND THE REDUCTION OF MORTALITY AND MORBIDITY RELATED TO ADVERSE CARDIAC EVENTS IN CHRONIC KIDNEY DISEASE PATIENTS
Applicant:
Keryx Biopharmaceuticals, Inc.
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-02-05 | ABN |
Abandonment | 2 | View | |
| 2024-12-31 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-12-31 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-06-06 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-06-06 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-06-06 | NTC.MISS.PRT |
Notice to File Missing Parts | 3 | View | |
| 2024-06-06 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-05-17 | APP.TEXT |
Application body structured text document | — | View | |
| 2024-05-17 | SPEC |
Specification | — | View | |
| 2024-05-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2024-05-17 | OATH |
Oath or Declaration filed | 3 | View | |
| 2024-05-17 | SPEC |
Specification | 132 | View | |
| 2024-05-17 | CLM |
Claims | 2 | View | |
| 2024-05-17 | ABST |
Abstract | 1 | View | |
| 2024-05-17 | PA.. |
Power of Attorney | 3 | View | |
| 2024-05-17 | SPEC |
Specification | 132 | View | |
| 2024-05-17 | CLM |
Claims | 2 | View | |
| 2024-05-17 | ABST |
Abstract | 1 | View | |
| 2024-05-17 | TRNA |
Transmittal of New Application | 2 | View | |
| 2024-05-17 | ADS |
Application Data Sheet | 10 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 154809
- Docket No.
- KRX-009US6
- Confirmation No.
- 1187
Parent
is a Continuation of
→
App. 18/480,876
Filed 2023-10-04
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 18/107,928
Filed 2023-02-09
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/845,355
Filed 2022-06-21
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/216,772
Filed 2018-12-11
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/031,678
Filed 2016-04-22
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/US2014/063643
Filed 2014-11-03
· Abandoned -- Incomplete Application (Pre-examination)
Parent
Claims priority from a provisional application
→
App. 61/899,866
Filed 2013-11-04
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/006,830
Filed 2024-12-31
· Docketed New Case - Ready for Examination
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/667,272
- Filed
- 2024-05-17
External Links